Showing results (431-440 of 824) with videos related to

Sort By:
Pageof 83
Seminars in Oncology|April 30, 2003
Expression of serotherapy target antigens in Waldenstrom's macroglobulinemia: therapeutic applications and considerationsSteven P Treon, Abigail Kelliher, Beverly Keele, et al.
Cancer Research|October 16, 2003
Effects of oligonucleotide N3'-->P5' thio-phosphoramidate (GRN163) targeting telomerase RNA in human multiple myeloma cellsMasaharu Akiyama, Teru Hideshima, Masood A Shammas, et al.
The EMBO Journal|February 25, 2006
Progressively impaired proteasomal capacity during terminal plasma cell differentiationSimone Cenci, Alexandre Mezghrani, Paolo Cascio, et al.
Oncology (Williston Park, N.Y.)|August 29, 2007
Novel therapeutic avenues in myeloma: changing the treatment paradigmJoanne Ghobrial, Irene M Ghobrial, Constantine Mitsiades, et al.
Proceedings of the National Academy of Sciences of the United States of America|January 19, 2008
MHC class I chain-related protein A antibodies and shedding are associated with the progression of multiple myelomaMasahisa Jinushi, Matthew Vanneman, Nikhil C Munshi, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|January 21, 2003
The role of cytotoxic therapy with hematopoietic stem cell transplantation in the therapy of multiple myeloma: an evidence-based reviewTheresa Hahn, John R Wingard, Kenneth C Anderson, et al.
Blood|October 18, 2003
Complete response to donor lymphocyte infusion in multiple myeloma is associated with antibody responses to highly expressed antigensRoberto Bellucci, Catherine J Wu, Sabina Chiaretti, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 21, 2009
Preclinical studies in support of defibrotide for the treatment of multiple myeloma and other neoplasiasConstantine S Mitsiades, Cecile Rouleau, Cinara Echart, et al.
JCI Insight|February 8, 2023
Heterogeneity of B cell lymphopoiesis in patients with premalignant and active myelomaJana Jakubikova, Danka Cholujova, Gabor Beke, et al.
Blood|January 17, 2013
Tumor-promoting immune-suppressive myeloid-derived suppressor cells in the multiple myeloma microenvironment in humansGüllü Topal Görgün, Gregory Whitehill, Jennifer L Anderson, et al.
Pageof 83